Niagen Bioscience, Inc. (NAGE)
NASDAQ: NAGE · Real-Time Price · USD
6.67
-0.10 (-1.48%)
At close: Dec 1, 2025, 4:00 PM EST
6.65
-0.02 (-0.33%)
After-hours: Dec 1, 2025, 7:34 PM EST

Niagen Bioscience Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
534406108125256297
Upgrade
Market Cap Growth
-0.23%277.18%-14.15%-50.96%-14.02%15.84%
Upgrade
Enterprise Value
47337785117226284
Upgrade
Last Close Price
6.675.301.431.683.744.80
Upgrade
PE Ratio
28.4047.50----
Upgrade
Forward PE
29.1650.28----
Upgrade
PS Ratio
4.204.081.291.743.795.02
Upgrade
PB Ratio
7.548.813.784.378.0618.11
Upgrade
P/TBV Ratio
7.588.883.854.488.2919.39
Upgrade
P/FCF Ratio
25.2633.9915.45---
Upgrade
P/OCF Ratio
24.9533.5415.13---
Upgrade
EV/Sales Ratio
3.793.781.011.623.354.79
Upgrade
EV/EBITDA Ratio
23.5644.12----
Upgrade
EV/EBIT Ratio
24.5148.76----
Upgrade
EV/FCF Ratio
22.3731.5412.17---
Upgrade
Debt / Equity Ratio
0.040.060.120.150.150.10
Upgrade
Debt / EBITDA Ratio
0.140.27----
Upgrade
Debt / FCF Ratio
0.140.220.47---
Upgrade
Asset Turnover
1.611.621.531.291.401.51
Upgrade
Inventory Turnover
3.073.212.252.072.052.07
Upgrade
Quick Ratio
3.232.961.571.611.891.17
Upgrade
Current Ratio
4.123.572.402.612.781.96
Upgrade
Return on Equity (ROE)
38.90%22.94%-17.29%-54.77%-112.68%-108.09%
Upgrade
Return on Assets (ROA)
15.60%7.84%-6.42%-20.81%-35.18%-31.57%
Upgrade
Return on Capital (ROIC)
21.74%12.00%-10.82%-33.57%-62.10%-61.70%
Upgrade
Return on Capital Employed (ROCE)
25.60%15.40%-16.30%-51.50%-67.30%-90.70%
Upgrade
Earnings Yield
3.82%2.10%-4.59%-13.19%-10.61%-6.70%
Upgrade
FCF Yield
3.96%2.94%6.47%-12.31%-9.61%-3.60%
Upgrade
Buyback Yield / Dilution
-10.80%-4.19%-7.54%-3.79%-10.02%-7.03%
Upgrade
Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q